The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Jardiance (empagliflozin)
Australian Public Assessment Report
Device/Product Name
Jardiance
Active ingredients
empagliflozin
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-05194-1-5
Submission Type
Extension of indication
Decision
Approved